We are live on
!
Find out more
FO
FT Options Portfolio holdings
AUM
$66.4M
1-Year Est. Return
18.48%
This Fund
S&P 500
This Quarter
Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
(+8.4%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
177.31%
Top 10 Holdings %
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.82M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$2.47M |
| 3 |
iShares Biotechnology ETF
IBB
|
+$2M |
| 4 |
Ulta Beauty
ULTA
|
+$1.86M |
| 5 |
MON
Monsanto Co
MON
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$7.18M |
| 2 |
Biogen
BIIB
|
+$4.33M |
| 3 |
Cal-Maine
CALM
|
+$3.64M |
| 4 |
Apple
AAPL
|
+$2.74M |
| 5 |
ALR
Alere Inc
ALR
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.95% |
| 2 | Consumer Staples | 5.72% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Technology | 3.35% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
Salesforce
CRM
$140B
| $112K | 0.09% |
16,200
+3,700
| +30% | +$289K |
|
|
SFLY
152
DELISTED
Shutterfly, Inc.
SFLY
| $112K | 0.09% |
+2,500
| New | +$124K |
|
|
CYBR
153
PUT
DELISTED
CyberArk
CYBR
| $111K | 0.09% |
11,000
-5,200
| -32% | -$277K |
|
154
PUT
Starbucks
SBUX
$120B
| $110K | 0.09% |
+32,500
| New | +$1.82M |
|
|
ASRT
155
CALL
DELISTED
Assertio
ASRT
| $109K | 0.09% |
+750
| New | +$942K |
|
|
ATXS
156
DELISTED
Astria Therapeutics
ATXS
| $109K | 0.09% |
296
+45
| +18% | +$11.9K |
|
|
157
PUT
Apple
AAPL
$4.9T
| $105K | 0.08% |
174,400
-130,400
| -43% | -$3.45M |
|
158
CALL
Acadia Pharmaceuticals
ACAD
$4.38B
| $99K | 0.08% |
10,200
-700
| -6% | -$23.7K |
|
|
DD
159
CALL
DELISTED
Du Pont De Nemours E I
DD
| $99K | 0.08% |
71,000
+43,900
| +162% | +$2.98M |
|
160
CALL
ASML
ASML
$671B
| $98K | 0.08% |
6,200
| – | – |
|
161
PUT
Mondelez International
MDLZ
$78.3B
| $98K | 0.08% |
52,500
+47,500
| +950% | +$2.08M |
|
162
PUT
TJX Companies
TJX
$171B
| $98K | 0.08% |
+90,600
| New | +$3.54M |
|
|
ITCI
163
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $98K | 0.08% |
+50,700
| New | +$2.05M |
|
164
PUT
Home Depot
HD
$338B
| $97K | 0.08% |
15,000
-5,800
| -28% | -$773K |
|
165
CALL
Adobe
ADBE
$94.3B
| $94K | 0.07% |
+13,200
| New | +$1.32M |
|
|
TWX
166
PUT
DELISTED
Time Warner Inc
TWX
| $94K | 0.07% |
32,500
+27,500
| +550% | +$2.15M |
|
|
ACOR
167
PUT
DELISTED
Acorda Therapeutics
ACOR
| $92K | 0.07% |
+183
| New | +$546K |
|
168
CALL
Agilent Technologies
A
$37.1B
| $91K | 0.07% |
142,000
+59,500
| +72% | +$2.78M |
|
169
CALL
Bausch Health
BHC
$1.8B
| $91K | 0.07% |
41,400
-3,100
| -7% | -$80.2K |
|
170
PUT
Alaunos Therapeutics
TCRT
$5.01M
| $86K | 0.07% |
923
+256
| +38% | +$206K |
|
171
PUT
IBM
IBM
$200B
| $81K | 0.06% |
+35,564
| New | +$5.4M |
|
172
CALL
Macy's
M
$6.23B
| $81K | 0.06% |
60,400
+20,000
| +50% | +$725K |
|
173
CALL
Microsoft
MSFT
$2.93T
| $77K | 0.06% |
+51,300
| New | +$2.9M |
|
|
TSRO
174
CALL
DELISTED
TESARO, Inc.
TSRO
| $77K | 0.06% |
13,900
-18,100
| -57% | -$1.69M |
|
|
175
CALL
Ulta Beauty
ULTA
$20.6B
| $76K | 0.06% |
23,800
+5,800
| +32% | +$1.47M |
|
Similar funds
MC
FIM
TLIC
MKCM
ACM
MFM
VE
GFWEV
FT Options's Q3 2016 Portfolio in Review
As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FT Options deployed $224M of net new capital in Q3 2016, opening 153 new positions and adding to 113 existing holdings. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $2.74M trimmed.
- FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
- FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
- FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
- FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
- FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
- FT Options opened 153 new positions and closed 127 in Q3 2016.
- FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.
Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.